跳至主要内容
临床试验/ITMCTR2000003376
ITMCTR2000003376招募中4 期

Clinical observation on the effect of Lingze tablet in the treatment of BPH patients in community hospitals in the real world

Dongzhimen Hospital Beijing University of Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
50 至 80(—)
性别
Male

入选标准

  • 1. Patients who meet the diagnostic criteria of BPH;
  • 2. Male patients aged 50-80 years;
  • 3. Patients who voluntarily sign informed consent.

排除标准

  • 1. Patients with BPH symptoms (such as diuretics, antihistamines or tricyclic antidepressants) were treated with other drugs with known efficacy within 4 weeks;
  • 2. Patients with other previous urinary system diseases (prostatitis, urinary incontinence, urethral stricture or prostate cancer), or previous lower urinary tract surgery;
  • 3. Patients with serious cardiovascular and cerebrovascular diseases, liver and kidney dysfunction and other serious primary diseases;
  • 4. Allergic constitution and patients with severe drug allergy history;
  • 5. Patients with mental diseases;
  • 6. Patients who participated in other clinical studies 6 months before the study.

研究者

发起方
Dongzhimen Hospital Beijing University of Chinese Medicine

相似试验